Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
combination drug
inhaler |
| gptkbp:activeIngredient |
gptkb:budesonide
gptkb:formoterol |
| gptkbp:drugClass |
gptkb:Corticosteroid
long-acting beta2-agonist |
| gptkbp:form |
metered dose inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Symbicort Rapihaler
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:marketedIn |
gptkb:Australia
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:products |
gptkb:Symbicort_Turbuhaler
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
thrush
headache tremor hoarseness palpitations |
| gptkbp:status |
approved
|
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Symbicort
|
| gptkbp:bfsLayer |
6
|